Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

BACKGROUND: Corticosteroids (CS) with or without adjuvant immunosuppressant agents are standard treatment for pemphigus vulgaris (PV). The efficacy of adjuvant therapies in minimizing steroid‐related adverse events (AEs) is unproven. OBJECTIVES: To utilize data collected in a French investigator‐ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, D.M., Odueyungbo, A., Csinady, E., Gearhart, L., Lehane, P., Cheu, M., Maho‐Vaillant, M., Prost‐Squarcioni, C., Hebert, V., Houivet, E., Calbo, S., Caillot, F., Golinski, M.L., Labeille, B., Picard‐Dahan, C., Paul, C., Richard, M.A., Bouaziz, J.D., Duvert‐Lehembre, S., Bernard, P., Caux, F., Alexandre, M., Ingen‐Housz‐Oro, S., Vabres, P., Delaporte, E., Quereux, G., Dupuy, A., Debarbieux, S., Avenel‐Audran, M., D'Incan, M., Bedane, C., Bénéton, N., Jullien, D., Dupin, N., Misery, L., Machet, L., Beylot‐Barry, M., Dereure, O., Sassolas, B., Benichou, J., Musette, P., Joly, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317434/
https://www.ncbi.nlm.nih.gov/pubmed/31487383
http://dx.doi.org/10.1111/bjd.18482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317434/
https://www.ncbi.nlm.nih.gov/pubmed/31487383
http://dx.doi.org/10.1111/bjd.18482

Ejemplares similares